Wells Fargo’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.6K | Buy |
15,325
+3,916
| +34% | +$15.7K | ﹤0.01% | 5024 |
|
|
2025
Q1 | $39.6K | Buy |
11,409
+253
| +2% | +$878 | ﹤0.01% | 5024 |
|
|
2024
Q4 | $73.4K | Buy |
11,156
+3,714
| +50% | +$24.4K | ﹤0.01% | 4861 |
|
|
2024
Q3 | $67.3K | Buy |
7,442
+4,101
| +123% | +$37.1K | ﹤0.01% | 4831 |
|
|
2024
Q2 | $53.6K | Sell |
3,341
-28
| -0.8% | -$449 | ﹤0.01% | 4904 |
|
|
2024
Q1 | $52.8K | Buy |
3,369
+3,297
| +4,579% | +$51.7K | ﹤0.01% | 4858 |
|
|
2023
Q4 | $966 | Buy |
+72
| New | +$966 | ﹤0.01% | 5789 |
|